Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Exp Lung Res ; 37(5): 279-90, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21309736

RESUMEN

Allergic inflammation is associated with increased generation and trafficking of inflammatory cells, especially eosinophils, to sites of inflammation. The effect of acute versus chronic airway allergen challenge on hematopoietic activity in the bone marrow (BM) and lungs was investigated using murine models of allergic airway inflammation. Acute allergen challenge induced proliferation of BM cells and significantly increased generation of eosinophil, but not multipotent, granulocyte-macrophage (GM), or B-lymphocyte progenitor cells. However, no hematopoietic activity was observed in the lungs. With chronic challenge, BM cells failed to proliferate, but exhibited increased capacity to generate multipotent as well as eosinophil, GM, and B-lymphocyte progenitors. In addition, increased generation of eosinophil- and GM-specific progenitors was observed in the lungs. Although no differences were observed in their ability to roll on BM endothelium in vitro or in vivo, CD34-enriched hematopoietic/stem progenitor cells (HSPCs) from chronic-, but not acute-, challenged mice demonstrated reduced migration across BM endothelial cells associated with decreased CXCR4 expression. Overall, these studies demonstrate that chronic allergen exposure can alter BM homing due to decreased transendothelial migration enabling noninteracting HSPCs to egress out of the BM and recruit to sites of inflammation such as the airways, resulting in extramedullary hematopoiesis.


Asunto(s)
Alérgenos/inmunología , Hematopoyesis Extramedular/inmunología , Inflamación/inmunología , Pulmón/inmunología , Alérgenos/administración & dosificación , Animales , Antígenos CD34/inmunología , Línea Celular , Movimiento Celular/inmunología , Eosinofilia/inmunología , Eosinofilia/metabolismo , Eosinófilos/inmunología , Eosinófilos/metabolismo , Inflamación/metabolismo , Pulmón/metabolismo , Ratones , Células Madre Multipotentes/inmunología , Células Madre Multipotentes/metabolismo , Células Progenitoras Mieloides/inmunología , Células Progenitoras Mieloides/metabolismo , Células Precursoras de Linfocitos B/inmunología , Células Precursoras de Linfocitos B/metabolismo , Receptores CXCR4/metabolismo
2.
Int J Oncol ; 35(2): 297-308, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19578743

RESUMEN

Although lymphatic dissemination is a major route for breast cancer metastasis, there has been little work to determine what factors control the ability of tumor cells to survive, establish and show progressive growth in a lymph node environment. This information is of particular relevance now, in the era of sentinel lymph node biopsy, where smaller intranodal tumor deposits are being detected earlier in the course of disease, the clinical relevance of which is uncertain. In this study, we compared differentially expressed genes in cell lines of high (468LN) vs. low (468GFP) lymphatic metastatic ability, and related these to clinical literature on genes associated with lymphatic metastatic ability and prognosis, to identify genes of potential clinical relevance. This approach revealed differential expression of a set of genes associated with 'cancer stem cell-like' properties, as well as networks of genes potentially associated with survival and autonomous growth. We explored these differences functionally and found that 468LN cells have a higher proportion of cells with a cancer stem cell-like (CD44+/CD24-) phenotype, have a higher clonogenic potential and a greater ability to survive, establish and grow in a foreign (lymph node and 3D Matrigel) microenvironment, relative to 468GFP cells. Differentially expressed genes which reflect these functions provide candidates for investigation as potential targets for therapy directed against early lymphatic metastasis.


Asunto(s)
Neoplasias de la Mama/patología , Perfilación de la Expresión Génica , Células Madre Neoplásicas/patología , Animales , Neoplasias de la Mama/genética , Antígeno CD24/análisis , Proliferación Celular , Supervivencia Celular , Femenino , Citometría de Flujo , Humanos , Receptores de Hialuranos/análisis , Metástasis Linfática , Ratones
3.
Stem Cells ; 24(11): 2373-81, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16825610

RESUMEN

The effect of sustained exposure to nicotine, a major constituent of cigarette smoke, on hematopoiesis in the bone marrow (BM) and spleen was evaluated in a murine model. BALB/c mice were exposed to nicotine subcutaneously using 21-day slow-release pellets. Exposure to nicotine had no effect on the proliferation of long-term BM cultures or on their ability to form colonies. However, there was a significant decrease in the generation of lineage-specific progenitor cells, specifically eosinophil (colony-forming unit [CFU]-Eos) progenitors, in the BM of nicotine-exposed mice compared with control mice. Surprisingly, sustained exposure of mice to nicotine was found to induce significant hematopoiesis in the spleen. There was a significant increase in total colony formation as well as eosinophil-, granulocyte-macrophage-, and B-lymphocyte-specific progenitors (CFU-Eos, CFU-GM, and CFU-B, respectively) in nicotine-exposed mice but not in control mice. Sustained exposure to nicotine was associated with significant inhibition of rolling and migration of enriched hematopoietic stem/progenitor cells (HSPCs) across BM endothelial cells (BMECs) in vitro as well as decreased expression of beta2 integrin on the surface of these cells. Although sustained exposure to nicotine has only a modest effect on BM hematopoiesis, our studies indicate that it significantly induces extramedullary hematopoiesis in the spleen. Decreased interaction of nicotine-exposed HSPCs with BMECs (i.e., rolling and migration) may result in altered BM homing of these cells, leading to their seeding and proliferation at extramedullary sites such as the spleen.


Asunto(s)
Células de la Médula Ósea/efectos de los fármacos , Hematopoyesis Extramedular/efectos de los fármacos , Células Madre Hematopoyéticas/efectos de los fármacos , Nicotina/farmacología , Bazo/efectos de los fármacos , Animales , Células de la Médula Ósea/inmunología , Antígenos CD18/análisis , Adhesión Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Línea Celular , Linaje de la Célula , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Femenino , Hematopoyesis/efectos de los fármacos , Células Madre Hematopoyéticas/inmunología , Ratones , Ratones Endogámicos BALB C , Modelos Animales , Fumar/efectos adversos , Bazo/inmunología , Bazo/patología
4.
J Immunol ; 173(6): 3599-603, 2004 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-15356103

RESUMEN

Elevated levels of serotonin (5-hydroxytryptamine, 5-HT) are observed in the serum of asthmatics. Herein, we demonstrate that 5-HT functions independently as an eosinophil chemoattractant that acts additively with eotaxin. 5-HT2A receptor antagonists (including MDL-100907 and cyproheptadine (CYP)) were found to inhibit 5-HT-induced, but not eotaxin-induced migration. Intravital microscopy studies revealed that eosinophils roll in response to 5-HT in venules under conditions of physiological shear stress, which could be blocked by pretreating eosinophils with CYP. OVA-induced pulmonary eosinophilia in wild-type mice was significantly inhibited using CYP alone and maximally in combination with a CCR3 receptor antagonist. Interestingly, OVA-induced pulmonary eosinophilia in eotaxin-knockout (Eot-/-) mice was inhibited by treatment with the 5-HT2A but not CCR3 receptor antagonist. These results suggest that 5-HT is a potent eosinophil-active chemoattractant that can function additively with eotaxin and a dual CCR3/5-HT2A receptor antagonist may be more effective in blocking allergen-induced eosinophil recruitment.


Asunto(s)
Adyuvantes Inmunológicos/fisiología , Quimiocinas CC/fisiología , Factores Quimiotácticos Eosinófilos/fisiología , Eosinófilos/citología , Eosinófilos/inmunología , Serotonina/fisiología , Adyuvantes Inmunológicos/antagonistas & inhibidores , Alérgenos/administración & dosificación , Inhibición de Migración Celular , Quimiocina CCL11 , Quimiocinas CC/deficiencia , Quimiocinas CC/genética , Quimiocinas CC/metabolismo , Factores Quimiotácticos Eosinófilos/antagonistas & inhibidores , Quimiotaxis de Leucocito/efectos de los fármacos , Quimiotaxis de Leucocito/inmunología , Ciproheptadina/farmacología , Relación Dosis-Respuesta Inmunológica , Eosinófilos/efectos de los fármacos , Fluorobencenos/farmacología , Humanos , Rodamiento de Leucocito/efectos de los fármacos , Piperidinas/farmacología , Eosinofilia Pulmonar/genética , Eosinofilia Pulmonar/inmunología , Eosinofilia Pulmonar/prevención & control , Receptores CCR3 , Receptores de Quimiocina/antagonistas & inhibidores , Serotonina/metabolismo , Antagonistas del Receptor de Serotonina 5-HT2 , Antagonistas de la Serotonina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA